Human SIRT1(Sirtuin 1) ELISA Kit
中文名称:人沉默调节蛋白1(SIRT1)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 0.31-20 ng/mL
- 灵敏度: 0.19 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人SIRT1抗体包被于酶标板上,实验时样品(或标准品)中的人SIRT1会与包被抗体结合。后依次加入生物素化的抗人SIRT1抗体和辣根过氧化物酶标记的亲和素,抗人SIRT1抗体与结合在包被抗体上的人SIRT1结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,SIRT1浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中SIRT1的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 0.31-20 ng/mL |
灵敏度 | 0.19 ng/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人SIRT1,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
Association between cognitive function and skeletal muscle in patients undergoing maintenance hemodialysis
IF: 5.200 -
Elucidation of anti-human melanoma and anti-aging mechanisms of compounds from green seaweed Caulerpa racemosa
IF: 3.800 -
HMGB 1 acetylation mediates trichloroethylene-induced immune kidney injury by facilitating endothelial cell-podocyte communication
IF: 6.800Journal: ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2023)PMID:37216866Reactivity:Human,MouseSample Type:serum -
Serum sirtuin1: a potential blood biomarker for early diagnosis of Alzheimer’s disease
IF: 5.200 -
The telomere-mitochondrial axis of aging in newborns
IF: 5.955 -
In vitro antiaging activity of polyphenol rich Polyalthia longifolia (Annonaceae) leaf extract in Saccharomyces cerevisiae BY611 yeast cells
IF: 5.195 -
Antiaging activity of polyphenol rich Calophyllum inophyllum L. fruit extract in Saccharomyces cerevisiae BY611 yeast cells
IF: 4.240 -
Klotho and SIRT1 changes from pre-diabetes to diabetes and pre-hypertension to hypertension
IF: 3.320 -
Plasma levels of sirtuin and adiponectin in patients with primary open-angle glaucoma, exfoliative glaucoma, and healthy controls
IF: 2.597Journal: EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)Reactivity:HumanSample Type:serum -
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease
IF: 4.936